Elizabeth Lumb and Chi Shing Fan
(PRESS RELEASE) PLEASANTON, CA — Responding to growing global interest in myopia management and its MiSight 1 day contact lenses, CooperVision’s Specialty EyeCare Division has named two eyecare-industry veterans to newly established professional services roles.
Elizabeth Lumb has been appointed as head of professional services, MiSight 1 day, EMEA (Europe, Middle East and Africa) and global brand manager for the lens. She joined the organization in 2013, serving as professional services training manager for Europe. Earlier in her career, she worked at Eurolens Research under the directorship of Professor Nathan Efron, conducting contact lens clinical research trials with findings presented at the American Academy of Optometry and BCLA conferences. Lumb was also a senior optometrist with Boots Opticians. She is based in the UK.
Chi Shing Fan, who led the test market introduction of MiSight in Hong Kong, has been appointed as professional service and commercial lead, MiSight & Specialty Business, Asia Pacific. He joined CooperVision in 2009, serving as professional services director, Asia Pacific and as the region’s frequent replacement category lead. Previously, he held regional professional services roles with Bausch + Lomb and CIBA Vision. Fan is based in Hong Kong.
“Closely partnering with eye care professionals is essential to advancing myopia management best practices, including embracing groundbreaking, proven technologies and educating parents,” said Stuart Cockerill, senior director, myopia management at CooperVision. “For more than two decades, Fan and Liz have earned the respect of colleagues and clinicians across Asia Pacific and EMEA. Their new focus will further accelerate adoption of MiSight, helping more children and their families benefit from this innovative approach.”
The company has also recently appointed MiSight Professional Services leads for the UK, France and Iberia. It intends to staff similar roles in Germany-Austria-Switzerland, Hong Kong and Singapore, aiding the establishment of myopia management best practices in those markets.
CooperVision MiSight is the world’s first 1-day soft contact lens shown to substantially slow the progression of myopia in children. In a global multicenter study, it has been shown to reduce the progression of myopia by 59 percent (SE) and 53 percent (eye elongation) over three years when compared to a group of children wearing a single vision 1-day lens.
The prevalence of myopia is projected to increase from approximately two billion people worldwide in 2010 to almost 5 billion people in 20503, bringing with it near- and long-term health challenges. Not only does it create blurred vision, but also increases the likelihood of conditions later in life such as glaucoma, cataract, retinal detachment and myopic maculopathy if not addressed.